Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation

Full metadata record
DC Field Value Language
dc.contributor.authorKim, Seung Hyun-
dc.contributor.authorNoh, Min Young-
dc.contributor.authorKim, Hee Jin-
dc.contributor.authorOh, Ki Wook-
dc.contributor.authorPark, Jin Seok-
dc.contributor.authorLee, Sanggon-
dc.contributor.authorMoon, Yeonsil-
dc.contributor.authorKim, Young-Eun-
dc.contributor.authorBae, Jae-Sung-
dc.contributor.authorJin, Hee Kyung-
dc.date.accessioned2022-07-09T14:51:23Z-
dc.date.available2022-07-09T14:51:23Z-
dc.date.created2021-05-11-
dc.date.issued2019-06-
dc.identifier.issn1738-1495-
dc.identifier.urihttps://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/147738-
dc.description.abstractAlzheimer's disease (AD), the most common form of dementia, has emerged as a major global public health challenge. However, the complexity of AD in its biological, genetic, and clinical aspects has hindered the development of effective therapeutic agents. Research plans that integrate new drug discoveries are urgently needed, including those based on novel and reliable biomarkers that reflect not only clinical phenotype, but also genetic and neuroimaging information. Therapeutic strategies such as stratification (i.e., subgrouping of patients having similar clinical characteristics or genetic background) and personalized medicine could be set as new directions for developing effective drugs for AD. In this review, we describe a therapeutic strategy that is based on immune-inflammation modulation for a subgroup of AD and related dementias, arguing that the use of stratification and personalized medicine is a promising way to achieve targeted medicine. The Korean AD Research Platform Initiative based on Immune-Inflammatory biomarkers (K-ARPI) has recently launched a strategy to develop novel biomarkers to identify a subpopulation of patients with AD and to develop new drug candidates for delaying the progression of AD by modulating toxic immune inflammatory response. Sphingosine kinase 1 (SphK1) and its metabolites, triggering receptor expressed on myeloid cells-2 (TREM2) related signals, and actin motility related proteins including Nck-associated protein 1 (Nap1) were selected as promising targets to modulate neuroinflammation. Their roles in stratification and personalized medicine will be discussed.-
dc.language영어-
dc.language.isoen-
dc.publisher대한치매학회-
dc.titleA Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation-
dc.typeArticle-
dc.contributor.affiliatedAuthorKim, Seung Hyun-
dc.contributor.affiliatedAuthorKim, Hee Jin-
dc.contributor.affiliatedAuthorOh, Ki Wook-
dc.contributor.affiliatedAuthorPark, Jin Seok-
dc.identifier.doi10.12779/dnd.2019.18.2.33-
dc.identifier.bibliographicCitationDementia and Neurocognitive Disorders(대한치매학회지), v.18, no.2, pp.33 - 46-
dc.relation.isPartOfDementia and Neurocognitive Disorders(대한치매학회지)-
dc.citation.titleDementia and Neurocognitive Disorders(대한치매학회지)-
dc.citation.volume18-
dc.citation.number2-
dc.citation.startPage33-
dc.citation.endPage46-
dc.type.rimsART-
dc.identifier.kciidART002487625-
dc.description.journalClass2-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClasskci-
dc.subject.keywordAuthorAlzheimer’s Disease-
dc.subject.keywordAuthorInflammation-
dc.subject.keywordAuthorPersonalized Medicine-
dc.subject.keywordAuthorBiomarkers-
dc.identifier.urlhttps://dnd.or.kr/DOIx.php?id=10.12779/dnd.2019.18.2.33-
Files in This Item
Appears in
Collections
서울 의과대학 > 서울 신경과학교실 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Seung Hyun photo

Kim, Seung Hyun
COLLEGE OF MEDICINE (DEPARTMENT OF NEUROLOGY)
Read more

Altmetrics

Total Views & Downloads

BROWSE